Capital Insight Partners’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.86M Sell
49,307
-8,108
-14% -$634K 0.67% 46
2025
Q1
$4.16M Sell
57,415
-5,077
-8% -$368K 0.73% 46
2024
Q4
$4.63M Buy
62,492
+2,164
+4% +$160K 0.8% 43
2024
Q3
$3.98M Buy
60,328
+4,290
+8% +$283K 0.7% 52
2024
Q2
$5.18M Sell
56,038
-459
-0.8% -$42.4K 0.98% 35
2024
Q1
$5.4M Buy
56,497
+6,602
+13% +$631K 1.01% 29
2023
Q4
$3.8M Buy
49,895
+1,589
+3% +$121K 0.78% 45
2023
Q3
$3.35M Buy
48,306
+2,546
+6% +$176K 0.76% 45
2023
Q2
$4.32M Sell
45,760
-163
-0.4% -$15.4K 0.97% 28
2023
Q1
$3.8M Buy
45,923
+891
+2% +$73.7K 0.89% 34
2022
Q4
$3.36M Buy
45,032
+1,267
+3% +$94.5K 0.87% 34
2022
Q3
$3.62M Buy
43,765
+607
+1% +$50.2K 0.97% 29
2022
Q2
$4.1M Buy
43,158
+314
+0.7% +$29.9K 0.96% 29
2022
Q1
$5.04M Buy
42,844
+2,572
+6% +$303K 1.03% 23
2021
Q4
$5.22M Buy
40,272
+846
+2% +$110K 1.06% 25
2021
Q3
$4.46M Sell
39,426
-16
-0% -$1.81K 0.97% 29
2021
Q2
$4.09M Buy
39,442
+1,007
+3% +$104K 0.92% 31
2021
Q1
$3.22M Buy
38,435
+1,813
+5% +$152K 0.78% 39
2020
Q4
$3.34M Buy
36,622
+588
+2% +$53.6K 0.84% 37
2020
Q3
$2.88M Buy
36,034
+33
+0.1% +$2.63K 0.81% 39
2020
Q2
$2.49M Buy
36,001
+670
+2% +$46.3K 0.78% 41
2020
Q1
$2.22M Buy
35,331
+3,390
+11% +$213K 1.17% 25
2019
Q4
$2.48M Sell
31,941
-468
-1% -$36.4K 1.14% 24
2019
Q3
$2.38M Sell
32,409
-750
-2% -$55K 2.08% 13
2019
Q2
$2.04M Buy
33,159
+129
+0.4% +$7.94K 1.77% 20
2019
Q1
$2.11M Buy
33,030
+159
+0.5% +$10.1K 1.9% 17
2018
Q4
$1.68M Buy
32,871
+144
+0.4% +$7.35K 1.73% 24
2018
Q3
$1.9M Buy
+32,727
New +$1.9M 1.67% 26